Moderna, Inc.
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
MRNA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US60770K1079
- LEI:
- Country:
- United States of America
- Address:
- 325 BINNEY STREET, 2142 CAMBRIDGE
- Website:
- https://www.modernatx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Moderna, Inc. is a biotechnology company pioneering messenger RNA (mRNA) science to create a new generation of transformative medicines and vaccines. The company's core platform technology is designed to instruct the body's cells to produce proteins that can prevent or treat diseases. This approach enables the rapid design and development of therapeutics and vaccines for a wide range of conditions. Moderna gained global recognition for developing one of the first highly effective COVID-19 vaccines. The company leverages its mRNA platform to advance a diverse clinical portfolio in areas including infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases, aiming to deliver on the promise of mRNA science for patients worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Moderna, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Moderna, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Moderna, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
